Evidence map›Paper›PMID 30353801›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2018

Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings.

Sandra Giménez, Laura Videla, Sergio Romero, Bessy Benejam, Susana Clos, Susana Fernández, Maribel Martínez, Maria Carmona-Iragui, Rosa M Antonijoan, Mercedes Mayos and 11 more

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06043440 (Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea), which is not on this map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06043440 phase2recruitingnot on this mapstarted 2023, after this paper: background citation

Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea

TypeinterventionalSponsorBrigham and Women's HospitalRan2023 to 2027Enrolled230ConditionsDown Syndrome, Obstructive Sleep ApneaArmsOxygen
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Sleep disorders in Down syndrome: a systematic review.Arquivos de neuro-psiquiatria · 2022
    Pooled it
  2. Article
  3. Article
  4. Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Impact of Alzheimer's disease on sleep in adults with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Review
  13. Neuronal oscillations in cognition: Down syndrome as a model of mouse to human translation.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  14. Observational
  15. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 3 countries.

Sandra GiménezMultidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Laura VidelaBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down Memory Unit, Barcelona, Spain.
Sergio RomeroBiomedical Engineering Research Centre, Department of Automatic Control, Universitat Politècnica de Catalunya, Barcelona, Spain.
Bessy BenejamBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down Memory Unit, Barcelona, Spain.
Susana ClosDrug Research Center, Institute for Biomedical Research Sant Pau (IIB Sant Pau), Department of Pharmacology and Therapeutics, Universitat Autònoma de Barcelona, Barcelona, Spain.
Susana FernándezBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down Memory Unit, Barcelona, Spain.
Maribel MartínezDrug Research Center, Institute for Biomedical Research Sant Pau (IIB Sant Pau), Department of Pharmacology and Therapeutics, Universitat Autònoma de Barcelona, Barcelona, Spain.
Maria Carmona-IraguiBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down Memory Unit, Barcelona, Spain.
Rosa M AntonijoanDrug Research Center, Institute for Biomedical Research Sant Pau (IIB Sant Pau), Department of Pharmacology and Therapeutics, Universitat Autònoma de Barcelona, Barcelona, Spain.
Mercedes MayosMultidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Ana FortunaMultidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Patricia PeñacobaMultidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Vicente PlazaMultidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Ricardo S OsorioCenter for Brain Health, Department of Psychiatry, NYU Langone Medical Center, New York, New York.
Ram A SharmaCenter for Brain Health, Department of Psychiatry, NYU Langone Medical Center, New York, New York.
Ignasi BardésBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down Memory Unit, Barcelona, Spain.
Anne-Sophie RebillatInstitut Jérôme Lejeune, París, France.
Alberto LleóDepartment of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau-Universitat Autònoma de Barcelona.
Rafael BlesaDepartment of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau-Universitat Autònoma de Barcelona.
Sebastian VidelaBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down Memory Unit, Barcelona, Spain.
Juan ForteaBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down Memory Unit, Barcelona, Spain.
Hospital de Sant Pau · ESUniversitat Autònoma de Barcelona · ESNYU Langone Health · USUniversitat de Barcelona · ESBiomedical Research Institute · USBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESCentro de Investigación Biomédica en Red · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESFondation Jérôme-Lejeune · FR

Funding

PSYCHOSOCIAL COREP30AG008051 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHAO, YONGZHAO · 1990 to 2019
$36.1M
Sleep Disordered Breathing in normal elderly and risk for Alzheimers DiseaseR01HL118624 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OSORIO, RICARDO S · 2013 to 2016
$2.7M
Brain Sleep Clearance of Amyloid-Beta Peptides Study (Brain SCRAPS)R21AG049348 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OSORIO, RICARDO S · 2015 to 2016
$454k
NHLBI NIH HHS R01 HL118624NIA NIH HHS P30 AG008051NIA NIH HHS R21 AG049348
6 · The paper itself

Abstract

STUDY

objectivesSleep problems are often undetected in adults with Down syndrome (DS). Our objective was to determine the prevalence of sleep disorders in adults with DS through self-reported and objective sleep measures.

methodsWe performed a community-based cross-sectional study of 54 adults with DS not referred for sleep disorders. Two polysomnography (PSG) sleep studies were performed. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI); daytime sleepiness was evaluated using the Epworth Sleepiness Scale (ESS) and the risk for the sleep apnea syndrome (OSA) was identified using the Berlin Questionnaire (BQ). Participants' sleep/wake pattern was assessed from sleep diaries and by wrist actigraphy. PSQI, ESS, and PSG measures were compared with 35 sex-, age-, and body mass index-matched patients in the control groups.

resultsIn PSG measures, adults with DS showed lower sleep efficiency (69 ± 17.7 versus 81.6 ± 11;

conclusionsAdults with DS show severe sleep disruption and a high prevalence of OSA, undetected by self-reported sleep measures. Actigraphy, PSG, and validated simplified devices for screening OSA should be routinely recommended for this population because treatment of sleep disorders can contribute to healthy aging.

Indexed as

ActigraphyAdultCross-Sectional StudiesDown SyndromeFemaleHumansMalePolysomnographyPrevalenceSelf ReportSleep Wake DisordersSurveys and QuestionnairesactigraphyagingDown syndromeobstructive sleep apneapolysomnographyself-reported sleep qualitysleep disruption

Identifiers

PMID30353801
PMCPMC6175810
OpenAlexW2897663096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.